enGene
(NASDAQ) ENGN
enGene Financials at a Glance
Market Cap
$119.24M
Revenue (TTM)
$0.00
Net Income (TTM)
-$66.40M
EPS (TTM)
-$2.18
P/E Ratio
-0.82
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$1.77
Volume
884,105.43
Open
$1.79
Price
$1.77
Volume
884,105.43
Open
$1.79
Previous Close
$1.78
Daily Range
$1.76 - $1.87
52-Week Range
$1.40 - $12.25
Estimated Earnings Date
Sep 14, 2026
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$1.77
Volume
884,105.43
Open
$1.79
Previous Close
$1.78
Daily Range
$1.76 - $1.87
52-Week Range
$1.40 - $12.25
Estimated Earnings Date
Sep 14, 2026
ENGN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout enGene
Industry
Biotechnology
Sector
Health CareEmployees
82
CEO
Ronald Harold Wilfred Cooper
Website
www.engene.comHeadquarters
Saint-Laurent, H4S 1Z9, CA
ENGN Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-29.34%
Return on Capital
-61.74%
Return on Assets
-21.59%
Earnings Yield
-1.22%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$119.24M
Shares Outstanding
66.99M
Volume
884.11K
Avg. Volume
1.69M
Financials (TTM)
Gross Profit
-$369.00K
Operating Income
-$68.65M
EBITDA
-$125.94M
Operating Cash Flow
-$110.00M
Capital Expenditure
-$1.39M
Free Cash Flow
-$111.39M
Cash & ST Invst.
$258.47M
Total Debt
$33.35M
enGene Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$180.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$119.24M
N/A
Market Cap/Employee
$2.13M
N/A
Employees
56
N/A
Net Income
$30.23M
+217.1%
EBITDA
-$31.79M
-28.5%
Quarterly Fundamentals
Total Cash
$258.47M
+18.9%
Total Debt
$33.35M
+31.5%
Accounts Receivable
$2.92M
+448.2%
Inventory
$0.00
N/A
Long Term Debt
$30.87M
+44.5%
Short Term Debt
$2.48M
-38.0%
Return on Assets
-21.59%
N/A
Return on Invested Capital
-24.00%
N/A
Free Cash Flow
-$30.60M
-33.1%
Operating Cash Flow
-$30.50M
-32.9%